Tru Singular Health raises $1M in first capital round
Tru Singular Health, a Delaware biotech corporation incorporated in 2026, closed a $1M offering under Regulation D exemption 6(b). The company is based in Natick, MA and has completed its initial raise with 12 investors.
Note: Company incorporated in 2026 and filed Form D in October 2026; first raise on Edgar. No placement agent listed despite successful close to 12 investors.
How this compares
- Among 440 fund launches filed from MA in the same window it is larger than 40%; the MA median is $2.2M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| Steven Gullans | Executive Officer, Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Steven Gullans, President.
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.